Trial Information

Summary: Belimumab in subjects with SLE

People with Systemic Lupus Erythematosis (SLE) are asked to participate in a research study being conducted by North Shore Long Island Jewish Health System.

You may be eligible to participate in this study if you:

• Are at least 18 years of age
• Have a diagnosis of SLE
• Have been on SLE medication (corticosteroids, immunosuppressive drugs, anti-malarias, or non-steroidal anti-inflammatory drugs) for more than 30 days.

You may not participate in this study if you:

• Have severe lupus kidney disease
• Have active central nervous system lupus
• Have had a major organ transplant
• Are HIV positive or have Hepatitis B
• Are pregnant, breastfeeding, or intend to become pregnant during the study
• Have participated in another research study within the last 60 days

For more information,

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 6:30:27 AM